Literature DB >> 15986875

A preliminary study of applying chemical biliary duct embolization to chemical hepatectomy in rats.

Fu Yu Li1, Jing Qiu Cheng, Sheng He, Ning Li, Ming Ming Zhang, Jia Hong Dong, Li Sheng Jiang, Nan Sheng Cheng, Xian Zhe Xiong.   

Abstract

The high recurrence of hepatolithiasis, together with the high operative risk of hepatectomy for specially located stones, has not been settled effectively to date. Thus, this study was designed to investigate the feasibility of applying chemical biliary duct embolization (CBDE) to chemical hepatectomy in rats. As revealed in our results, the intrahepatic biliary ducts could be partially or completely occluded by both phenol and absolute ethanol. In addition, the embolization effect was greatly enhanced by further using cyanoacrylate. Also noteworthy is that CBDE resulted in massive death of hepatocytes, which were replaced by proliferated bile ductules and collagen. More importantly, the hepatocytes disappeared completely in the periphery of the embolized lobe where chemical hepatectomy was achieved. As for the comparison of embolic agents, the combination of phenol and cyanoacrylate exhibited even better fibrogenic effects than the combination of ethanol and cyanoacrylate. In conclusion, CBDE might be a promising approach for achieving the effects of chemical hepatectomy. The combination of phenol and cyanoacrylate potentially acted as a more effective agent for biliary duct embolization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986875     DOI: 10.1007/s10620-005-2725-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases.

Authors:  D Fournier; K G TerBrugge; R Willinsky; P Lasjaunias; W Montanera
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

2.  Suppression of proliferative cholangitis in a rat model with direct adenovirus-mediated retinoblastoma gene transfer to the biliary tract.

Authors:  R Terao; K Honda; E Hatano; T Uehara; M Yamamoto; Y Yamaoka
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

3.  [Surgical treatment of high biliary stricture complicating intrahepatic stones].

Authors:  J X Cai
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1988-09

4.  Biliary strictures as a cause of primary intrahepatic bile duct stones.

Authors:  Y Matsumoto; H Fujii; M Yoshioka; T Sekikawa; T Wada; M Yamamoto; H Eguchi; K Sugahara
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

5.  Ablation of the cystic duct and gallbladder: clinical observations.

Authors:  C D Becker; J S Fache; D E Malone; J L Stoller; H J Burhenne
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

6.  Gallbladder ablation with gallstones in situ in an animal model.

Authors:  L S Kannegieter; J C Brandon; F P Espinoza; D T Vanson; L S Deutsch; D P Miller; S K Teplick
Journal:  Invest Radiol       Date:  1993-05       Impact factor: 6.016

7.  Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.

Authors:  B Gerling; M Becker; J Waldschmidt; M Rehmann; D Schuppan
Journal:  J Hepatol       Date:  1996-07       Impact factor: 25.083

8.  Endoscopic treatment of biliary leakage with n-butyl-2 cyanoacrylate.

Authors:  Stefan Seewald; Stefan Groth; Parupudi V J Sriram; He Xikun; Thawatchai Akaraviputh; Gerardo Mendoza; Boris Brand; Uwe Seitz; Frank Thonke; Nib Soehendra
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

9.  Hepatolithiasis in East Asia. Retrospective study.

Authors:  F Nakayama; R D Soloway; T Nakama; K Miyazaki; H Ichimiya; P C Sheen; C G Ker; G B Ong; T K Choi; J Boey
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

10.  Injection of a silicone prepolymer system into the gallbladder of rabbits.

Authors:  T G Mahon; K C Wright; C D Armeniades
Journal:  Invest Radiol       Date:  1991-10       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.